GNAS mutations, depending on the molecular detection method used, can be identified in 45%–88% of FD cases and are not present in other fibro-osseous lesions such as cemento-ossifying fibroma, cemento-osseous dysplasia or low-grade osteosarcoma [29, 30]. This evidence concerns the gene GNAS and Fabry disease.